omniture

Equity Research for NASDAQ's Top Price Gainer: Priceline.com, Mako Surgical, & Regeneron Pharmaceuticals


VANCOUVER, British Columbia, September 20, 2011 /PRNewswire-Asia/ -- Pennystocksinsiders.com has issued Equity Research for the following top percentage gainers in NASDAQ: Priceline.com (NASDAQ:PCLN), Mako Surgical (NASDAQ:MAKO), & Regeneron Pharmaceuticals (NASDAQ:REGN)

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Research Report Summary:

Priceline.com (NASDAQ:PCLN): Strong upward price momentum, but insiders are selling BIG

Ranked 3rd place on Sep 19 for top price gainers in NASDAQ, stock price up US$5.75
Ranked 2nd place on Sep 14 for top price gainers in NASDAQ, stock price up US$6.11
Ranked 2nd place on Sep 12 for top price gainers in NASDAQ, stock price up US$8.1

Insider Trade Signals: Stock price gained strong upward momentum in the past week. However, we found multi-million stock sales made by company Executive officers and Directors including President and CEO - Jeffery H. Boyd and Executive VP, General Counsel - Peter J. Millones. Total insider net stock sales reached 18.2 Million. Want to know why company executives are selling?

Read Full Report: http://www.pennystocksinsiders.com/PR/092011B/PCLN/Priceline.pdf

Mako Surgical (NASDAQ:MAKO): Insiders are selling at 3 month high

Ranked 6rd place on Sep 19 for top price gainers in NASDAQ, stock price up 11.61%

Ranked 9th place on Sep 14 for top percentage gainers in NASDAQ, stock price up 34.89%

Insider Trade Signals: Company stock price reached 3 month high at US$40.81. PSI found 3 senior executive offers making large stock sales including President, CEO and Chairman - Maurice R. Ferre, SVP, CFO and Treasurer - Fritze L. Laporte and SVP Strategic - Ivan Delevic. Want to find out why insiders are cashing out at the 3 month high? They might be offering some good stock tips.


Read Full Report: http://www.pennystocksinsiders.com/PR/092011B/MAKO/MakoSurgical.pdf

Regeneron Pharmaceuticals (NASDAQ:REGN): Stock price strong rebound observed

Ranked 4th place on Sep 19 for top price gainers in NASDAQ, stock price up 7.89%

Ranked 4th place on Sep 14 for top price losers in NASDAQ, stock price down 3.26%

Ranked 7th place on Sep 9 for top price losers in NASDAQ, stock price down 9.05%

Insider Trade Signals: Stock is currently trading near YTD high. Insiders are taking advantage of a stock price rally and are cashing out. Found more than 12 company executives sold stocks or exercised option sales over the past 4 weeks. Total insider net stock sales reached 21.8 Million. Insiders selling near YTD high could be a strong downward price trend indicator. Want to know why?

Read Full Report: http://www.pennystocksinsiders.com/PR/092011B/REGN/Regeneron.pdf

More Individual Stock Reports & Sector Reports:
http://www.pennystocksinsiders.com/mediaroom/

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Pennystocksinsiders.com:

Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:

Please visit http://www.pennystocksinsiders.com/disclaimers/index.php for details.

Source: Pennystocksinsiders.com; Insiderslab.com
collection